HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen-Jen Hwu Selected Research

docosahexaenoyl-paclitaxel

12/2010Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma.
8/2009Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen-Jen Hwu Research Topics

Disease

86Melanoma (Melanoma, Malignant)
01/2021 - 05/2002
40Neoplasms (Cancer)
01/2021 - 05/2002
15Neoplasm Metastasis (Metastasis)
10/2020 - 12/2005
13Disease Progression
12/2019 - 08/2009
13Brain Neoplasms (Brain Tumor)
12/2019 - 06/2002
3Fatigue
09/2014 - 08/2011
2Enterocolitis
04/2019 - 10/2018
2Thrombocytopenia (Thrombopenia)
01/2019 - 02/2012
2Colitis
11/2018 - 10/2018
2Renal Cell Carcinoma (Grawitz Tumor)
01/2018 - 02/2012
2Sarcoma (Soft Tissue Sarcoma)
09/2017 - 11/2003
2Pneumonia (Pneumonitis)
01/2017 - 05/2015
2Acute Kidney Injury (Acute Renal Failure)
05/2015 - 09/2014
2Uveal melanoma
01/2015 - 12/2010
2Exanthema (Rash)
09/2014 - 09/2014
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2014 - 02/2013
2Keratoacanthoma
07/2014 - 02/2013
2Lung Neoplasms (Lung Cancer)
02/2012 - 12/2005
2Lymphopenia (Lymphocytopenia)
06/2010 - 07/2009
1Nevus (Nevi)
10/2020
1Diarrhea
10/2018
1Fever (Fevers)
01/2018
1Headache (Headaches)
01/2018
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2018
1Pain (Aches)
01/2018
1Chills
01/2018
1Leukemia
09/2017
1Orbital Diseases
07/2017
1Autoimmune Diseases (Autoimmune Disease)
01/2017

Drug/Important Bio-Agent (IBA)

16pembrolizumabIBA
01/2021 - 07/2013
15Immune Checkpoint InhibitorsIBA
01/2021 - 07/2013
15IpilimumabIBA
10/2020 - 06/2012
13Temozolomide (Temodar)FDA LinkGeneric
10/2017 - 06/2002
10Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2014
8Monoclonal AntibodiesIBA
01/2018 - 11/2003
7Dacarbazine (DIC)FDA LinkGeneric
08/2014 - 08/2009
6Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2012
6CTLA-4 AntigenIBA
10/2020 - 12/2011
6Interleukin-2 (IL2)IBA
12/2018 - 02/2011
5Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 12/2005
5NivolumabIBA
11/2018 - 05/2015
5Cisplatin (Platino)FDA LinkGeneric
08/2014 - 06/2009
4Adrenal Cortex Hormones (Corticosteroids)IBA
04/2019 - 10/2012
4Pharmaceutical PreparationsIBA
01/2019 - 08/2011
4LigandsIBA
07/2018 - 06/2012
4InterferonsIBA
08/2014 - 02/2011
4Thalidomide (Thalomid)FDA Link
10/2006 - 06/2002
3Infliximab (Remicade)FDA Link
04/2019 - 10/2018
3VemurafenibIBA
01/2019 - 07/2014
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019 - 09/2014
3Immunologic Adjuvants (Immunologic Adjuvant)IBA
12/2018 - 05/2002
3B7-H1 AntigenIBA
10/2018 - 12/2016
3dabrafenibIBA
01/2018 - 02/2013
3VaccinesIBA
05/2013 - 07/2004
2Carboplatin (JM8)FDA LinkGeneric
01/2019 - 12/2005
2130-nm albumin-bound paclitaxelIBA
11/2018 - 08/2014
2SteroidsIBA
10/2018 - 01/2017
2trametinibIBA
01/2018 - 08/2016
2AntibodiesIBA
01/2018 - 11/2003
2Monophenol Monooxygenase (Tyrosinase)IBA
09/2017 - 05/2002
2Interferon-alpha (Interferon Alfa)IBA
08/2017 - 08/2012
2Cancer VaccinesIBA
11/2015 - 05/2013
2AlbuminsIBA
08/2014 - 12/2011
2AntigensIBA
05/2013 - 06/2010
2Peptides (Polypeptides)IBA
05/2013 - 05/2002
2Vinblastine (Vinblastine Sulfate)FDA Link
10/2012 - 02/2011
2docosahexaenoyl-paclitaxelIBA
12/2010 - 08/2009
2saponin QA-21V1 (QS21)IBA
11/2003 - 05/2002
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021
1CateninsIBA
10/2020
1CreatinineIBA
01/2019
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2018
1cyclopropapyrroloindoleIBA
10/2018
1MK-8353IBA
01/2018
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2018
1peginterferon alfa-2b (Pegintron)FDA Link
01/2018
1SCH772984IBA
01/2018
1alpha-AmylasesIBA
01/2018
1C-Reactive ProteinIBA
01/2018
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2018
1InterleukinsIBA
01/2018
1Investigational DrugsIBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Interleukin-9 (Interleukin 9)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
09/2017
1Immunomodulating AgentsIBA
02/2017
1Formaldehyde (Formol)FDA Link
01/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2017
1tremelimumabIBA
11/2015
1CytokinesIBA
11/2015
1Immunoglobulin G (IgG)IBA
11/2015

Therapy/Procedure

48Therapeutics
11/2020 - 09/2003
17Immunotherapy
01/2020 - 07/2004
11Drug Therapy (Chemotherapy)
11/2018 - 06/2005
4Aftercare (After-Treatment)
07/2017 - 11/2003
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2018 - 12/2012
2Lymph Node Excision (Lymph Node Dissection)
02/2009 - 02/2003
1Withholding Treatment
11/2018
1Electric Stimulation Therapy (Electrotherapy)
01/2018
1Precision Medicine
01/2016